Same Drug Class

Imatinib vs Ipilimumab

Imatinib vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Imatinib and Ipilimumab.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Imatinib β€” 18 hours; Ipilimumab β€” 14.7 days.

Chemical Properties

Molecular Formula: Imatinib β€” C29H31N7O.

Molecular Weight: Imatinib β€” 493.6030 g/mol.

Type: Imatinib β€” Small molecule; Ipilimumab β€” Antibody.